Literature DB >> 35449241

Risk factors of enterostomy in neonates with Hirschsprung disease.

Zhaozhou Liu1, Yanan Zhang1, Shuangshuang Li1, Shen Yang1, Jiawei Zhao1, Ting Yang1, Siqi Li1, Yongwei Chen1, Weihong Guo1, Dawei Hou1, Jingbin Du1, Yingzi Li1, Jinshi Huang2.   

Abstract

PURPOSE: This study was aiming to explore the risk factors contributing to enterostomy in neonates with Hirschsprung disease (HD) to provide a reference for clinicians to make treatment decisions.
METHODS: Medical records of 284 patients diagnosed with HD during the neonatal period were retrospectively analyzed. The patients were divided into 2 groups based on operative intervention (one stage transanal pull-through, versus enterotomy and staged transanal pull-through). Univariate and multivariable logistic regression analysis was performed to identify risk factors contributing to enterostomy.
RESULTS: The incidence of enterostomy was 12.0% (34/284) in neonates with HD. Univariate and multivariate logistic regression analysis showed that serum albumin < 25.4 g/L, radiographic results as subphrenic free air, and level of aganglionosis with long-segment or total colonic aganglionosis (TCA) were independent risk factors of enterostomy in neonates, with OR of 42.045 (6.131, 288.319), 285.558 (26.651, 3059.694) and 15.573 (4.319, 56.157), respectively.
CONCLUSIONS: The low serum albumin level, bowel perforation, and level of aganglionosis with long-segment or TCA could influence the occurrence of enterostomy in neonates with HD.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Enterostomy; Hirschsprung disease; Neonates; Risk factors

Mesh:

Substances:

Year:  2022        PMID: 35449241     DOI: 10.1007/s00384-022-04151-5

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  17 in total

1.  Evolution in the management of Hirschsprung's disease in the UK and Ireland: a national survey of practice revisited.

Authors:  T J Bradnock; G M Walker
Journal:  Ann R Coll Surg Engl       Date:  2010-08-24       Impact factor: 1.891

Review 2.  Hirschsprung Disease - Current Diagnosis and Management.

Authors:  Kanishka Das; Suravi Mohanty
Journal:  Indian J Pediatr       Date:  2017-06-10       Impact factor: 1.967

Review 3.  Hirschsprung disease.

Authors:  Jacob C Langer
Journal:  Curr Opin Pediatr       Date:  2013-06       Impact factor: 2.856

4.  Hirschsprung's disease: the Australian Paediatric Surveillance Unit's experience.

Authors:  S J Singh; G D H Croaker; P Manglick; C L Wong; H Athanasakos; E Elliott; D Cass
Journal:  Pediatr Surg Int       Date:  2003-04-03       Impact factor: 1.827

5.  Single-stage versus multi-stage pull-through for Hirschsprung's disease: practice trends and outcomes in infants.

Authors:  Jason P Sulkowski; Jennifer N Cooper; Anthony Congeni; Erik G Pearson; Benedict C Nwomeh; Edward J Doolin; Martin L Blakely; Peter C Minneci; Katherine J Deans
Journal:  J Pediatr Surg       Date:  2014-07-10       Impact factor: 2.545

6.  Clinical features of Hirschsprung's disease associated with Down syndrome: a 30-year retrospective nationwide survey in Japan.

Authors:  Satoshi Ieiri; Mayumi Higashi; Risa Teshiba; Isamu Saeki; Genshiro Esumi; Junko Akiyoshi; Takanori Nakatsuji; Tomoaki Taguchi
Journal:  J Pediatr Surg       Date:  2009-12       Impact factor: 2.545

Review 7.  Symptomatology, pathophysiology, diagnostic work-up, and treatment of Hirschsprung disease in infancy and childhood.

Authors:  Fleur de Lorijn; Guy E Boeckxstaens; Marc A Benninga
Journal:  Curr Gastroenterol Rep       Date:  2007-06

8.  Diagnosis of Hirschsprung Disease.

Authors:  Lusine Ambartsumyan; Caitlin Smith; Raj P Kapur
Journal:  Pediatr Dev Pathol       Date:  2019-12-02

9.  The use of stomas in the early management of Hirschsprung disease: Findings of a national, prospective cohort study.

Authors:  T J Bradnock; M Knight; S Kenny; M Nair; G M Walker
Journal:  J Pediatr Surg       Date:  2017-05-11       Impact factor: 2.545

Review 10.  ERNICA guidelines for the management of rectosigmoid Hirschsprung's disease.

Authors:  Kristiina Kyrklund; Cornelius E J Sloots; Ivo de Blaauw; Kristin Bjørnland; Udo Rolle; Duccio Cavalieri; Paola Francalanci; Fabio Fusaro; Annette Lemli; Nicole Schwarzer; Francesco Fascetti-Leon; Nikhil Thapar; Lars Søndergaard Johansen; Dominique Berrebi; Jean-Pierre Hugot; Célia Crétolle; Alice S Brooks; Robert M Hofstra; Tomas Wester; Mikko P Pakarinen
Journal:  Orphanet J Rare Dis       Date:  2020-06-25       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.